Literature DB >> 16219658

Predictors of mortality and morbidity in patients with chronic heart failure.

Stuart J Pocock1, Duolao Wang, Marc A Pfeffer, Salim Yusuf, John J V McMurray, Karl B Swedberg, Jan Ostergren, Eric L Michelson, Karen S Pieper, Christopher B Granger.   

Abstract

AIMS: We aimed to develop prognostic models for patients with chronic heart failure (CHF). METHODS AND
RESULTS: We evaluated data from 7599 patients in the CHARM programme with CHF with and without left ventricular systolic dysfunction. Multi-variable Cox regression models were developed using baseline candidate variables to predict all-cause mortality (n=1831 deaths) and the composite of cardiovascular (CV) death and heart failure (HF) hospitalization (n=2460 patients with events). Final models included 21 predictor variables for CV death/HF hospitalization and for death. The three most powerful predictors were older age (beginning >60 years), diabetes, and lower left ventricular ejection fraction (EF) (beginning <45%). Other independent predictors that increased risk included higher NYHA class, cardiomegaly, prior HF hospitalization, male sex, lower body mass index, and lower diastolic blood pressure. The model accurately stratified actual 2-year mortality from 2.5 to 44% for the lowest to highest deciles of predicted risk.
CONCLUSION: In a large contemporary CHF population, including patients with preserved and decreased left ventricular systolic function, routine clinical variables can discriminate risk regardless of EF. Diabetes was found to be a surprisingly strong independent predictor. These models can stratify risk and help define how patient characteristics relate to clinical course.

Entities:  

Mesh:

Year:  2005        PMID: 16219658     DOI: 10.1093/eurheartj/ehi555

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  225 in total

1.  Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension.

Authors:  Michele Correale; Deodata Montrone; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Clin Res Cardiol       Date:  2012-03-02       Impact factor: 5.460

2.  Ivabradine in heart failure: to SHIFT or not to SHIFT.

Authors:  Andres Schuster; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 3.  The role of radionuclide imaging in heart failure.

Authors:  Vinay Gulati; Gilbert Ching; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

Review 4.  Predicting survival in heart failure.

Authors:  Viorel G Florea; Inder S Anand
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

Review 5.  Prognostic factors in patients hospitalized for heart failure.

Authors:  Lakshmi Sridharan; Liviu Klein
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 6.  How does renal denervation lower blood pressure and when should this technique be considered for the treatment of hypertension?

Authors:  Kui Toh Gerard Leong; Henry Krum
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

7.  The impact of medication nonadherence on the relationship between mortality risk and depression in heart failure.

Authors:  Emily C Gathright; Mary A Dolansky; John Gunstad; Joseph D Redle; Richard A Josephson; Shirley M Moore; Joel W Hughes
Journal:  Health Psychol       Date:  2017-07-20       Impact factor: 4.267

8.  National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy.

Authors:  Madhab Lamichhane; Joseph C Gardiner; Nicole R Bianco; Steven J Szymkiewicz; Ranjan K Thakur
Journal:  J Interv Card Electrophysiol       Date:  2016-10-17       Impact factor: 1.900

Review 9.  Heart failure in elderly patients: distinctive features and unresolved issues.

Authors:  Valentina Lazzarini; Robert J Mentz; Mona Fiuzat; Marco Metra; Christopher M O'Connor
Journal:  Eur J Heart Fail       Date:  2013-02-20       Impact factor: 15.534

Review 10.  Sympathetic Activation in Chronic Heart Failure: Potential Benefits of Interventional Therapies.

Authors:  Kamila Lachowska; Marcin Gruchała; Krzysztof Narkiewicz; Dagmara Hering
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.